Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MIST |
---|---|---|
09:32 ET | 1311 | 1.51 |
09:36 ET | 400 | 1.51 |
09:38 ET | 10740 | 1.5 |
09:41 ET | 400 | 1.505 |
09:50 ET | 500 | 1.5086 |
09:54 ET | 6000 | 1.5 |
09:56 ET | 1000 | 1.5001 |
10:01 ET | 350 | 1.51 |
10:06 ET | 10100 | 1.49 |
10:08 ET | 100 | 1.49 |
10:24 ET | 700 | 1.5 |
10:32 ET | 561 | 1.505 |
10:35 ET | 1300 | 1.52 |
10:48 ET | 500 | 1.5101 |
11:02 ET | 4934 | 1.5101 |
11:06 ET | 102 | 1.52 |
11:08 ET | 800 | 1.5 |
11:15 ET | 900 | 1.4901 |
11:24 ET | 1858 | 1.51 |
11:27 ET | 13000 | 1.51 |
11:29 ET | 3155 | 1.5 |
11:36 ET | 2793 | 1.5099 |
11:44 ET | 200 | 1.5049 |
11:58 ET | 800 | 1.5099 |
12:02 ET | 100 | 1.53 |
12:03 ET | 1307 | 1.52 |
12:09 ET | 100 | 1.53 |
12:14 ET | 10492 | 1.51 |
12:23 ET | 798 | 1.5 |
12:36 ET | 489 | 1.5 |
12:41 ET | 478 | 1.4999 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Milestone Pharmaceuticals Inc | 79.9M | -1.2x | --- |
Serina Therapeutics Inc | 79.2M | -0.7x | --- |
Barinthus Biotherapeutics PLC | 74.6M | -1.1x | --- |
Entera Bio Ltd | 80.5M | -8.0x | --- |
Anixa Biosciences Inc | 77.5M | -7.1x | --- |
Elicio Therapeutics Inc | 81.1M | -1.2x | --- |
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $79.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 53.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.73 |
EPS | $-1.25 |
Book Value | $0.50 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.